AU2010226476B2 - Fatty acid monoglyceride compositions - Google Patents

Fatty acid monoglyceride compositions Download PDF

Info

Publication number
AU2010226476B2
AU2010226476B2 AU2010226476A AU2010226476A AU2010226476B2 AU 2010226476 B2 AU2010226476 B2 AU 2010226476B2 AU 2010226476 A AU2010226476 A AU 2010226476A AU 2010226476 A AU2010226476 A AU 2010226476A AU 2010226476 B2 AU2010226476 B2 AU 2010226476B2
Authority
AU
Australia
Prior art keywords
composition
group
present
acid
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2010226476A
Other languages
English (en)
Other versions
AU2010226476A1 (en
Inventor
Hans Hofland
Edward Hsia
Barry Hunt
Jon Lenn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stiefel Research Australia Pty Ltd
Stiefel Laboratories Inc
Original Assignee
Stiefel Research Australia Pty Ltd
Stiefel Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42740006&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2010226476(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stiefel Research Australia Pty Ltd, Stiefel Laboratories Inc filed Critical Stiefel Research Australia Pty Ltd
Publication of AU2010226476A1 publication Critical patent/AU2010226476A1/en
Application granted granted Critical
Publication of AU2010226476B2 publication Critical patent/AU2010226476B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2010226476A 2009-03-20 2010-03-19 Fatty acid monoglyceride compositions Active AU2010226476B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20263509P 2009-03-20 2009-03-20
US61/202,635 2009-03-20
US21331309P 2009-05-28 2009-05-28
US61/213,313 2009-05-28
PCT/US2010/027905 WO2010108060A1 (en) 2009-03-20 2010-03-19 Fatty acid monoglyceride compositions

Publications (2)

Publication Number Publication Date
AU2010226476A1 AU2010226476A1 (en) 2011-09-22
AU2010226476B2 true AU2010226476B2 (en) 2013-02-07

Family

ID=42740006

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010226476A Active AU2010226476B2 (en) 2009-03-20 2010-03-19 Fatty acid monoglyceride compositions

Country Status (15)

Country Link
US (2) US20110305646A1 (enExample)
EP (1) EP2408299B1 (enExample)
JP (1) JP5992324B2 (enExample)
KR (1) KR101506369B1 (enExample)
CN (1) CN102368904B (enExample)
AU (1) AU2010226476B2 (enExample)
BR (1) BRPI1014529A2 (enExample)
CA (1) CA2756047C (enExample)
CL (1) CL2011002302A1 (enExample)
EA (1) EA022569B1 (enExample)
ES (1) ES2437395T3 (enExample)
IL (1) IL214887A (enExample)
MX (1) MX2011009781A (enExample)
PL (1) PL2408299T3 (enExample)
WO (1) WO2010108060A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2434892B1 (en) * 2009-05-29 2015-08-19 Palau Pharma, S.A. Azole antifungal compositions
CA2775393C (en) * 2012-05-02 2014-04-29 Samy Saad Topical non-aqueous pharmaceutical formulations
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US20160166491A1 (en) * 2014-03-26 2016-06-16 Mandom Corporation Deodorant composition and deodorant agent
CN104672506A (zh) * 2015-02-02 2015-06-03 安徽玉堂雨具有限公司 一种抗菌防霉生物降解塑料及其制备方法
EP3468544A2 (en) * 2016-06-13 2019-04-17 Vyome Therapeutics Limited Synergistic antifungal compositions and methods thereof
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
AU2020408342B2 (en) * 2019-12-20 2024-02-22 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Topical pharmaceutical compositions for treating onychomycosis
KR102442047B1 (ko) * 2020-09-10 2022-09-08 서울대학교산학협력단 설페이트와 아민기를 함유하는 지방산 글리세리드 화합물, 이의 생산 방법, 및 용도

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465423A2 (en) * 1990-06-25 1992-01-08 Research Foundation for Mental Hygiene, Inc. Antimicrobial fatty compositions
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
DE19540465A1 (de) * 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
WO2006017594A2 (en) * 2004-08-03 2006-02-16 Regents Of The University Of Minnesota Fatty-acid derivatives of glycerol for treating microbial infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067997A (en) * 1975-05-21 1978-01-10 Med-Chem Laboratories Synergistic microbecidal composition and method
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
RU2122402C1 (ru) * 1995-07-18 1998-11-27 Научно-производственная фирма "Фаркос" Товарищество с ограниченной ответственностью Средство для лечения и профилактики грибковых заболеваний кожи на основе гризеофульвина
CA2278328C (en) * 1998-02-09 2008-07-22 Macrochem Corporation Antifungal nail lacquer and method using same
PL357111A1 (en) * 2000-02-16 2004-07-12 Bentley Pharmaceuticals, Inc. Pharmaceutical composition
JP2004043336A (ja) * 2002-07-10 2004-02-12 Naris Cosmetics Co Ltd 抗菌剤及びそれを配合してなる化粧料
KR20050030205A (ko) * 2002-07-22 2005-03-29 시바 스폐셜티 케미칼스 홀딩 인코포레이티드 공중합체 및 개인 케어 조성물에의 용도
US20050165104A1 (en) * 2002-07-24 2005-07-28 Holwerda James G. Biocidal agents and veterinary methods
EP1633818A2 (en) * 2003-04-18 2006-03-15 MERCK PATENT GmbH Antimicrobial pigments
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
RU2337689C1 (ru) * 2007-04-18 2008-11-10 Общество с ограниченной ответственностью "Фармацевтические технологии" Средство для лечения поверхностных микозов
AU2009240389A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions for treating fungal, yeast and mold infections

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465423A2 (en) * 1990-06-25 1992-01-08 Research Foundation for Mental Hygiene, Inc. Antimicrobial fatty compositions
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
DE19540465A1 (de) * 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
WO2006017594A2 (en) * 2004-08-03 2006-02-16 Regents Of The University Of Minnesota Fatty-acid derivatives of glycerol for treating microbial infections

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PLOCKOVA ET AL, "Inhibition of food moulds by lauric acid derivatives", ADV. FOOD SCI. (CMTL), Vol. 21, No. 1/2, 1999, pages 44-47 *
RUZICKA ET AL, "Antimicrobial effects of 1-monoacylglycerols prepared by catalytic reaction of glycidol with fatty acids", EUR. FOOD RES. TECHNOL., Vol. 217, No. 4, 2003, pages 329-331 *

Also Published As

Publication number Publication date
ES2437395T3 (es) 2014-01-10
WO2010108060A1 (en) 2010-09-23
CA2756047C (en) 2016-04-26
EA022569B1 (ru) 2016-01-29
CN102368904A (zh) 2012-03-07
BRPI1014529A2 (pt) 2015-08-25
WO2010108060A8 (en) 2011-12-29
CL2011002302A1 (es) 2012-06-22
EA201171150A1 (ru) 2012-03-30
IL214887A0 (en) 2011-11-30
EP2408299A4 (en) 2012-08-15
IL214887A (en) 2015-09-24
CN102368904B (zh) 2014-03-26
JP5992324B2 (ja) 2016-09-14
EP2408299B1 (en) 2013-10-23
US20110305646A1 (en) 2011-12-15
CA2756047A1 (en) 2010-09-23
KR20120014553A (ko) 2012-02-17
EP2408299A1 (en) 2012-01-25
US20180360791A1 (en) 2018-12-20
AU2010226476A1 (en) 2011-09-22
JP2012521351A (ja) 2012-09-13
KR101506369B1 (ko) 2015-03-30
MX2011009781A (es) 2011-10-17
PL2408299T3 (pl) 2014-03-31

Similar Documents

Publication Publication Date Title
AU2010226476B2 (en) Fatty acid monoglyceride compositions
US10251885B2 (en) Azole antifungal compositions
US20100267678A1 (en) Flux-enabling compositions and methods for dermal delivery of drugs
CA2633472A1 (en) Flux-enabling compositions and methods for dermal delivery of drugs
AU2010302940A1 (en) Cosmetic foam
WO2005087270A1 (en) Anti-vaginitis compositions comprising a triazole
US8841351B2 (en) Polymeric topical compositions
JP2009519956A (ja) 薬物の皮膚送達のための組成物および方法
US20190358160A1 (en) Sub-micron emulsions
AU2010238566B2 (en) Polymeric topical compositions

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ LENN, JON; HUNT, BARRY; HSIA, EDWARD AND HOFLAND, HANS .

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ LENN, JON; HUNT, BARRY; HSIA, EDWARD AND HOFLAND, HANS

FGA Letters patent sealed or granted (standard patent)